R+D CSIC

Compounds to enhance immune responses

The CSIC and two universities from Spain have synthesised new compounds to promote proliferation of natural killer T-cells, involved in immune responses.

These compounds are more versatile modulators of cytokine production and have longer life than alpha-galactosylceramide. They have potential as vaccine adjuvants and drugs for autoimmune diseases, infections or cancer. Pharmaceutical and biotechnological companies are sought to collaborate under a patent license.

Contact:
Vicepresidencia Adjunta
de Transferencia del Conocimiento CSIC
Institut de Química Avançada de Catalunya
Isabel Massip
Tel. +(34) 93 400 61 00
This email address is being protected from spambots. You need JavaScript enabled to view it.

• Prev
• Next